SI2621477T1 - Peroralna farmacevtska tableta za nadzirano sproščanje mesalazina in postopek pridobivanja le-te - Google Patents

Peroralna farmacevtska tableta za nadzirano sproščanje mesalazina in postopek pridobivanja le-te

Info

Publication number
SI2621477T1
SI2621477T1 SI201130177T SI201130177T SI2621477T1 SI 2621477 T1 SI2621477 T1 SI 2621477T1 SI 201130177 T SI201130177 T SI 201130177T SI 201130177 T SI201130177 T SI 201130177T SI 2621477 T1 SI2621477 T1 SI 2621477T1
Authority
SI
Slovenia
Prior art keywords
mesalazine
obtaining
oral pharmaceutical
pharmaceutical tablet
controled release
Prior art date
Application number
SI201130177T
Other languages
English (en)
Inventor
Blas David Loeches
Fernandez-Molina Roberto Varas
Perez Mercedes Martinez
Original Assignee
Laboratorios Liconsa, S.A.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Laboratorios Liconsa, S.A. filed Critical Laboratorios Liconsa, S.A.
Publication of SI2621477T1 publication Critical patent/SI2621477T1/sl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/60—Salicylic acid; Derivatives thereof
    • A61K31/606—Salicylic acid; Derivatives thereof having amino groups
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/284—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone
    • A61K9/2846—Poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
SI201130177T 2010-12-27 2011-12-23 Peroralna farmacevtska tableta za nadzirano sproščanje mesalazina in postopek pridobivanja le-te SI2621477T1 (sl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP10382355A EP2468264A1 (en) 2010-12-27 2010-12-27 Oral pharmaceutical tablet for controled release of mesalazine and process for obtaining it
PCT/EP2011/073983 WO2012089677A1 (en) 2010-12-27 2011-12-23 Oral pharmaceutical tablet for controled release of mesalazine and process for obtaining it
EP11805527.6A EP2621477B1 (en) 2010-12-27 2011-12-23 Oral pharmaceutical tablet for controled release of mesalazine and process for obtaining it

Publications (1)

Publication Number Publication Date
SI2621477T1 true SI2621477T1 (sl) 2014-07-31

Family

ID=43901549

Family Applications (1)

Application Number Title Priority Date Filing Date
SI201130177T SI2621477T1 (sl) 2010-12-27 2011-12-23 Peroralna farmacevtska tableta za nadzirano sproščanje mesalazina in postopek pridobivanja le-te

Country Status (17)

Country Link
US (1) US20130273156A1 (sl)
EP (2) EP2468264A1 (sl)
JP (1) JP2014501267A (sl)
CN (1) CN103269691A (sl)
BR (1) BR112013016461A2 (sl)
CA (1) CA2822754A1 (sl)
DK (1) DK2621477T3 (sl)
ES (1) ES2463040T3 (sl)
HK (1) HK1184391A1 (sl)
HR (1) HRP20140479T1 (sl)
PL (1) PL2621477T3 (sl)
PT (1) PT2621477E (sl)
RS (1) RS53363B (sl)
RU (1) RU2013125148A (sl)
SA (1) SA111330110B1 (sl)
SI (1) SI2621477T1 (sl)
WO (1) WO2012089677A1 (sl)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX369967B (es) * 2013-02-22 2019-11-27 Zeria Pharm Co Ltd Tableta recubierta enterica.
CN103211780B (zh) * 2013-04-17 2015-10-14 沈阳药科大学 美沙拉嗪口服结肠定位粘附微丸
EP3227273B1 (en) 2014-12-02 2022-02-09 Minerva Neurosciences, Inc. Compositions comprising 2-((1-(2(4-fluorophenyl)-2-oxoethyl)piperidin-4-yl)methyl)isoindolin-1-one for treating schizophrenia
EP3162362A1 (de) 2015-10-30 2017-05-03 Dr. Falk Pharma Gmbh Optimierte mesalazinhaltige hochdosistablette
ITUB20160203A1 (it) * 2016-01-19 2017-07-19 Valpharma Int Spa Formulazioni in compresse a rilascio modificato contenenti Mesalazina ad alto dosaggio, processo per la loro preparazione e loro uso.
ITUA20162293A1 (it) * 2016-04-05 2017-10-05 Sofar Spa Processo per formulazioni solide di mesalazina
AU2017252407A1 (en) 2016-04-19 2018-11-01 Ferring B.V. Oral pharmaceutical compositions of nicotinamide
JP2019513800A (ja) * 2016-04-19 2019-05-30 フェリング ベスローテン フェンノートシャップ メサラジンの経口薬学的組成物
CN105902500B (zh) * 2016-04-27 2019-11-29 上海理工大学 一种美沙拉嗪肠溶定位控释制剂及其制备方法
IL308650A (en) * 2017-06-21 2024-01-01 Minerva Neurosciences Inc Stomach-resistant controlled-release oral dosage forms
WO2020041504A1 (en) 2018-08-21 2020-02-27 Minerva Neurosciences, Inc. Use of roluperidone to treat negative symptoms and disorders, increase neuroplasticity, and promote neuroprotection
IT201800011120A1 (it) * 2018-12-14 2020-06-14 Dpl Pharma S P A Composizioni farmaceutiche orali solide per la somministrazione di mesalazina o suoi derivati
IT202000011050A1 (it) * 2020-05-14 2021-11-14 Mogon Pharmaceuticals Sagl Composizioni orali solide comprendenti matrici monolitiche composite per la somministrazione cronotropica nel tratto gastroenterico di ingredienti attivi

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2692484B1 (fr) * 1992-06-22 1995-06-30 Gouchet Franck Nouvelle forme galenique de 4-asa a liberation controlee.
ITMI991316A1 (it) 1999-06-14 2000-12-14 Cip Ninety Two 92 S A Composizioni farmaceutiche orali a rilascio modificato di mesalazina
US20020044962A1 (en) * 2000-06-06 2002-04-18 Cherukuri S. Rao Encapsulation products for controlled or extended release
IT1318625B1 (it) * 2000-07-14 2003-08-27 Roberto Valducci Formulazioni farmaceutiche solide orali a rilascio multifasicoph-dipendente.
US20070059368A1 (en) * 2005-05-31 2007-03-15 Cherukuri S R Modified release formulations of anti-irritability drugs
US20040005358A1 (en) * 2002-04-23 2004-01-08 Slugg Peter H. Modified-release vasopeptidase inhibitor formulation, combinations and method
US7825106B2 (en) * 2003-09-03 2010-11-02 Agi Therapeutics Ltd. Modified release formulations and methods of treating inflammatory bowel disease
TW200517106A (en) * 2003-10-29 2005-06-01 Wyeth Corp Sustained release pharmaceutical compositions
JP2008504250A (ja) * 2004-06-28 2008-02-14 ソルベイ・フアーマシユーチカルズ・ベー・ブイ 胃貯留特性を有する経口用徐放性テジサミル製剤。
PT1781292E (pt) * 2004-07-15 2010-12-23 Abbott Healthcare Products Bv Formulação de libertação prolongada de 3-amino-8-{1-piperazinil)- 2h-1-benzopirano-2-ona
JP5041774B2 (ja) * 2006-09-22 2012-10-03 日本ケミファ株式会社 メサラジンを有効成分として含有する徐放性錠剤

Also Published As

Publication number Publication date
EP2621477B1 (en) 2014-03-19
PL2621477T3 (pl) 2014-08-29
CN103269691A (zh) 2013-08-28
RS53363B (en) 2014-10-31
DK2621477T3 (da) 2014-06-16
EP2468264A1 (en) 2012-06-27
WO2012089677A1 (en) 2012-07-05
EP2621477A1 (en) 2013-08-07
US20130273156A1 (en) 2013-10-17
ES2463040T3 (es) 2014-05-27
JP2014501267A (ja) 2014-01-20
HRP20140479T1 (hr) 2014-07-04
RU2013125148A (ru) 2015-02-10
CA2822754A1 (en) 2012-07-05
HK1184391A1 (en) 2014-01-24
BR112013016461A2 (pt) 2016-09-27
PT2621477E (pt) 2014-05-30
SA111330110B1 (ar) 2014-08-11

Similar Documents

Publication Publication Date Title
SI2621477T1 (sl) Peroralna farmacevtska tableta za nadzirano sproščanje mesalazina in postopek pridobivanja le-te
CY2020008I2 (el) Φαρμακοτεχνικες μορφες διστρωματικου δισκιου
HK1255336A1 (zh) 藥物製劑及其製備方法
IL220037A0 (en) Compressible-coated pharmaceutical composiitons and tablets and methods of manufacture
PL2595597T3 (pl) Urządzenie i sposób kapsułkowania kapsułek lub innych stałych postaci leku w kapsułkach
EP2448406A4 (en) ORAL PHARMACEUTICAL COMPOSITIONS OF 3-HYDROXY-N-METHYLMORPHINAN WITH DELAYED RELEASE AND METHOD OF USE THEREOF
IL216526A (en) A pharmaceutical dosage form is heat-dissolved and a method of preparing such a pharmaceutical dosage form
IL219276A0 (en) Gastroretentive dosage forms of poorly soluble drugs
EP2502199A4 (en) METHOD AND DEVICE FOR CONFORMITY REVIEW IN THE ADMINISTRATION OF MEDICAMENTS
EP2564845A4 (en) MEDICINE FOR TREATING HYPERPLASIC AND INFLAMMATORY DISORDERS IN HUMANS BASED ON DIINDOLYLMETHANE
ZA201402864B (en) A gastroretentive dosage system and process of preparation thereof
HK1183228A1 (zh) 口服藥物治療方法和組合物
IL225606A0 (en) A method for preparing an inactive supplement suitable for pharmaceutical use
PT2665471T (pt) Formas de dosagem farmacêutica orais de libertação controlada que compreendem mgbg
HUE037197T2 (hu) Javított kioldódású meszalazin tabletta
HK1214519A1 (zh) 雙用途硫酸鹽口服藥物組合物片劑及其使用方法
ZA201304731B (en) Pharmaceutical composites of poorly water soluble drugs and polymers
RS55359B1 (sr) Kapsula i uređaj za korišćenje navedene kapsule
EP2760435A4 (en) AUTHENTICABLE COATINGS FOR PHARMACEUTICAL TABLETS AND INGREDIENTS
SI2654723T1 (sl) Trdne farmacevtske dozirna oblike, ki obsegajo tadalafil in metode za njihovo pripravo
PL2561864T3 (pl) Tabletka powlekana zawierająca tianeptynę i sposób jej otrzymywania
ZA201303663B (en) Apparatus for conducting oral care experiments and method of forming and using the same
BR112013014963A2 (pt) comprimido farmacêutico de liberação controlada para administração oral
PL2651390T3 (pl) Orodyspersyjna tabletka farmaceutyczna na bazie zolpidemu
HU1000215D0 (en) Pharmaceutical composition containing nanostructured telmisartan and process for producing it